175 related articles for article (PubMed ID: 31263095)
1. IL-32γ suppresses lung cancer stem cell growth via inhibition of ITGAV-mediated STAT5 pathway.
Lee YS; Kim KC; Mongre RK; Kim JY; Kim YR; Choi DY; Song S; Yun J; Han SB; Yoon DY; Hong JT
Cell Death Dis; 2019 Jul; 10(7):506. PubMed ID: 31263095
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of skin carcinogenesis by suppression of NF-κB dependent ITGAV and TIMP-1 expression in IL-32γ overexpressed condition.
Lee YS; Lee CH; Bae JT; Nam KT; Moon DB; Hwang OK; Choi JS; Kim TH; Jun HO; Jung YS; Hwang DY; Han SB; Yoon DY; Hong JT
J Exp Clin Cancer Res; 2018 Nov; 37(1):293. PubMed ID: 30486830
[TBL] [Abstract][Full Text] [Related]
3. BTB and CNC homology 1 (Bach1) induces lung cancer stem cell phenotypes by stimulating CD44 expression.
Jiang P; Li F; Liu Z; Hao S; Gao J; Li S
Respir Res; 2021 Dec; 22(1):320. PubMed ID: 34949193
[TBL] [Abstract][Full Text] [Related]
4. IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.
Oh JH; Cho MC; Kim JH; Lee SY; Kim HJ; Park ES; Ban JO; Kang JW; Lee DH; Shim JH; Han SB; Moon DC; Park YH; Yu DY; Kim JM; Kim SH; Yoon DY; Hong JT
Oncogene; 2011 Jul; 30(30):3345-59. PubMed ID: 21423208
[TBL] [Abstract][Full Text] [Related]
5. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
[TBL] [Abstract][Full Text] [Related]
6. IL-32γ enhances TNF-α-induced cell death in colon cancer.
Park ES; Yoo JM; Yoo HS; Yoon DY; Yun YP; Hong J
Mol Carcinog; 2014 Feb; 53 Suppl 1():E23-35. PubMed ID: 23255489
[TBL] [Abstract][Full Text] [Related]
7. IL-32 gamma reduces lung tumor development through upregulation of TIMP-3 overexpression and hypomethylation.
Yun J; Park MH; Son DJ; Nam KT; Moon DB; Ju JH; Hwang OK; Choi JS; Kim TH; Jung YS; Hwang DY; Han SB; Yoon DY; Hong JT
Cell Death Dis; 2018 Feb; 9(3):306. PubMed ID: 29467412
[TBL] [Abstract][Full Text] [Related]
8. IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer.
Lee SO; Yang X; Duan S; Tsai Y; Strojny LR; Keng P; Chen Y
Oncotarget; 2016 Feb; 7(6):6626-38. PubMed ID: 26675547
[TBL] [Abstract][Full Text] [Related]
9. IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation.
Chen Y; Zhang F; Tsai Y; Yang X; Yang L; Duan S; Wang X; Keng P; Lee SO
Radiat Oncol; 2015 Nov; 10():227. PubMed ID: 26572130
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma.
Liu CL; Chen YJ; Fan MH; Liao YJ; Mao TL
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899775
[TBL] [Abstract][Full Text] [Related]
11. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
[TBL] [Abstract][Full Text] [Related]
12. Truncated Bid Overexpression Induced by Recombinant Adenovirus Cre/LoxP System Suppresses the Tumorigenic Potential of CD133
Long Q; Zhu W; Zhou J; Wu J; Lu W; Zheng C; Zhou D; Yu L; Yang R
Oncol Res; 2017 Apr; 25(4):595-603. PubMed ID: 27760587
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-135a-induced formation of CD133+ subpopulation with cancer stem cell properties in cervical cancer.
Leung CON; Deng W; Ye TM; Ngan HYS; Tsao SW; Cheung ANY; Ziru N; Yuen DCK; Pang RTK; Yeung WSB
Carcinogenesis; 2020 Nov; 41(11):1592-1604. PubMed ID: 32415843
[TBL] [Abstract][Full Text] [Related]
14. Suppressing STAT5 signaling affects osteosarcoma growth and stemness.
Subramaniam D; Angulo P; Ponnurangam S; Dandawate P; Ramamoorthy P; Srinivasan P; Iwakuma T; Weir SJ; Chastain K; Anant S
Cell Death Dis; 2020 Feb; 11(2):149. PubMed ID: 32094348
[TBL] [Abstract][Full Text] [Related]
15. Radiotheranostic Targeting Cancer Stem Cells in Human Colorectal Cancer Xenografts.
She X; Qin S; Jing B; Jin X; Sun X; Lan X; An R
Mol Imaging Biol; 2020 Aug; 22(4):1043-1053. PubMed ID: 32125599
[TBL] [Abstract][Full Text] [Related]
16. CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel.
Aghajani M; Mokhtarzadeh A; Aghebati-Maleki L; Mansoori B; Mohammadi A; Safaei S; Asadzadeh Z; Hajiasgharzadeh K; Khaze Shahgoli V; Baradaran B
Mol Biol Rep; 2020 May; 47(5):3691-3703. PubMed ID: 32246247
[TBL] [Abstract][Full Text] [Related]
17. CD133 inhibition via autophagic degradation in pemetrexed-resistant lung cancer cells by GMI, a fungal immunomodulatory protein from Ganoderma microsporum.
Hsin IL; Chiu LY; Ou CC; Wu WJ; Sheu GT; Ko JL
Br J Cancer; 2020 Aug; 123(3):449-458. PubMed ID: 32448867
[TBL] [Abstract][Full Text] [Related]
18. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
[TBL] [Abstract][Full Text] [Related]
19. Combined Poziotinib with Manidipine Treatment Suppresses Ovarian Cancer Stem-Cell Proliferation and Stemness.
Lee H; Kim JW; Lee DS; Min SH
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036254
[TBL] [Abstract][Full Text] [Related]
20. Arsenite inhibits the function of CD133
Tang H; Jin Y; Jin S; Tan Z; Peng Z; Kuang Y
Tumour Biol; 2016 Oct; 37(10):14103-14115. PubMed ID: 27517564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]